EMG
VAXX

ETF Managers Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

ETF Managers Group’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$99.5K Buy
43,836
+12,409
+39% +$31.5K ﹤0.01% 634
2022
Q4 		$44K Sell
31,427
-5,762
-15% -$9.68K ﹤0.01% 500
2022
Q3 		$74K Sell
37,189
-2,617
-7% -$5.45K ﹤0.01% 662
2022
Q2 		$62K Buy
39,806
+1,965
+5% +$7.43K ﹤0.01% 699
2022
Q1 		$167K Sell
37,841
-43
-0.1% -$237 ﹤0.01% 610
2021
Q4 		$211K Buy
+37,884
New +$392K ﹤0.01% 609

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SM
Scoggin Management New York $254M AUM 232.32% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return